Contribution of Alcoholic and Nonalcoholic Fatty Liver Disease to the Burden of Liver-Related Morbidity and Mortality

Mishra, 2012, Epidemiology and natural history of non-alcoholic fatty liver disease, J Clin Exp Hepatol, 2, 135, 10.1016/S0973-6883(12)60102-9 Trimble, 2013, Mortality associated with alcohol-related liver disease, Aliment Pharmacol Ther, 38, 596, 10.1111/apt.12432 Rehm, 2013, Global burden of alcoholic liver diseases, J Hepatol, 59, 160, 10.1016/j.jhep.2013.03.007 Zhu, 2015, Prevalence of nonalcoholic fatty liver disease and economy, Dig Dis Sci, 60, 3194, 10.1007/s10620-015-3728-3 Meikle, 2015, Circulating lipids are associated with alcoholic liver cirrhosis and represent potential biomarkers for risk assessment, PLoS One, 10, e0130346, 10.1371/journal.pone.0130346 Mann, 2003, The epidemiology of alcoholic liver disease, Alcohol Res Health, 27, 209 Clark, 2006, The epidemiology of nonalcoholic fatty liver disease in adults, J Clin Gastroenterol, 40, S5 Clark, 2002, Nonalcoholic fatty liver disease, Gastroenterology, 122, 1649, 10.1053/gast.2002.33573 Rehm, 2013, Alcohol and mortality: global alcohol-attributable deaths from cancer, liver cirrhosis, and injury in 2010, Alcohol Res, 35, 174 Beste, 2015, Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013, Gastroenterology, 149, 1471, 10.1053/j.gastro.2015.07.056 Haflidadottir, 2014, Long-term follow-up and liver-related death rate in patients with non-alcoholic and alcoholic related fatty liver disease, BMC Gastroenterol, 14, 166, 10.1186/1471-230X-14-166 Younossi, 2015, Economic and quality-of-life implications of non-alcoholic fatty liver disease, Pharmacoeconomics, 33, 1245, 10.1007/s40273-015-0316-5 Dan, 2007, Health-related quality of life in patients with non-alcoholic fatty liver disease, Aliment Pharmacol Ther, 26, 815, 10.1111/j.1365-2036.2007.03426.x Afendy, 2009, Predictors of health-related quality of life in patients with chronic liver disease, Aliment Pharmacol Ther, 30, 469, 10.1111/j.1365-2036.2009.04061.x Golabi, 2016, Nonalcoholic fatty liver disease (NAFLD) is associated with impairment of health related quality of life (HRQOL), Health Qual Life Outcomes, 14, 18, 10.1186/s12955-016-0420-z Marchesini, 2001, Factors associated with poor health-related quality of life of patients with cirrhosis, Gastroenterology, 120, 170, 10.1053/gast.2001.21193 Younossi, 2001, Health-related quality of life in chronic liver disease: the impact of type and severity of disease, Am J Gastroenterol, 96, 2199, 10.1111/j.1572-0241.2001.03956.x Younossi, 2015, Trends in outpatient resource utilizations and outcomes for Medicare beneficiaries with nonalcoholic fatty liver disease, J Clin Gastroenterol, 49, 222, 10.1097/MCG.0000000000000071 Jinjuvadia, 2015, Translational research and evolving alcoholic hepatitis treatment consortium. Trends in alcoholic hepatitis-related hospitalizations, financial burden, and mortality in the United States, J Clin Gastroenterol, 49, 506, 10.1097/MCG.0000000000000161 Centers for Disease Control and Prevention. Excessive drinking costs U.S. $223.5 billion. Available at: http://www.cdc.gov/features/alcoholconsumption. Accessed: October 28, 2015. Bouchery, 2011, Economic costs of excessive alcohol consumption in the U.S., 2006, Am J Prev Med, 41, 516, 10.1016/j.amepre.2011.06.045 World Health Organization. Global status report on noncommunicable diseases 2010. Available at: http://www.who.int/nmh/publications/ncd_report_full_en.pdf. Accessed: November 12, 2015. Saad J, Volk N, Shah S, et al. The epidemiology and costs of alcoholic cirrhosis in the United States. A review of 50,567 admissions from the 2012 National Inpatient Sample. Available at: http://www.aasld.org/liver-learning. Last accessed on 4/28/2016. Younossi, 2011, Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008, Clin Gastroenterol Hepatol, 9, 524, 10.1016/j.cgh.2011.03.020 Younossi, 2015, Global epidemiology of non-alcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence and outcomes, Hepatology Kanwal, 2016, Trends in the burden of nonalcoholic fatty liver disease in a United States cohort of veterans, Clin Gastroenterol Hepatol, 14, 301, 10.1016/j.cgh.2015.08.010 Zhang, 2015, Global publication trends and research hotspots of nonalcoholic fatty liver disease: a bibliometric analysis and systematic review, Springerplus, 4, 776, 10.1186/s40064-015-1542-1 2014, Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013, Lancet, 384, 766, 10.1016/S0140-6736(14)60460-8 Doycheva, 2016, Non-invasive screening for NAFLD and advanced fibrosis in diabetes in primary care setting by MRI and MRE, Aliment Pharmacol Ther, 43, 83, 10.1111/apt.13405 Ong, 2005, Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients, Obes Surg, 15, 310, 10.1381/0960892053576820 Mathurin, 2009, Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease, Gastroenterology, 137, 532, 10.1053/j.gastro.2009.04.052 Merriman, 2006, Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease, Hepatology, 44, 874, 10.1002/hep.21346 Lassailly, 2015, Bariatric surgery reduces features of nonalcoholic steatohepatitis in morbidly obese patients, Gastroenterology, 149, 379, 10.1053/j.gastro.2015.04.014 Younossi, 2012, Nonalcoholic fatty liver disease in lean individuals in the United States, Medicine, 91, 319, 10.1097/MD.0b013e3182779d49 Xu, 2013, Prevalence and risk factors for the development of nonalcoholic fatty liver disease in a nonobese Chinese population: the Zhejiang Zhenhai Study, Am J Gastroenterol, 108, 1299, 10.1038/ajg.2013.104 Substance Abuse and Mental Health Services Administration (SAMHSA). 2013 National Survey on Drug Use and Health (NSDUH). Table 2.41B—Alcohol use in lifetime, past year, and past month among persons aged 18 or older, by demographic characteristics: percentages, 2012 and 2013. Available at: http://www.samhsa.gov/data/sites/default/files/NSDUH-DetTabsPDFWHTML2013/Web/HTML/NSDUH-DetTabsSect2peTabs1to42-2013.htm#tab2.41b. Accessed: October 28, 2015. World Health Organization. Global status report on alcohol and health, p. XIV. 2014 ed. Available at: http://www.who.int/substance_abuse/publications/global_alcohol_report/msb_gsr_2014_1.pdf?ua=1. Accessed: October 28, 2015. Naveau, 1997, Excess weight risk factor for alcoholic liver disease, Hepatology, 25, 108, 10.1002/hep.510250120 Kraus, 2015, Changes in mortality due to major alcohol-related diseases in four Nordic countries, France and Germany between 1980 and 2009: a comparative age-period-cohort analysis, Addiction, 110, 1443, 10.1111/add.12989 Younossi, 2004, Nonalcoholic fatty liver disease in patients with type 2 diabetes, Clin Gastroenterol Hepatol, 2, 262, 10.1016/S1542-3565(04)00014-X Stepanova, 2010, Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study, Gut, 59, 1410, 10.1136/gut.2010.213553 Hossain, 2009, Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease, Clin Gastroenterol Hepatol, 7, 1224, 10.1016/j.cgh.2009.06.007 Younossi, 2013, In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not, Metabolism, 62, 352, 10.1016/j.metabol.2012.08.005 Weston, 2005, Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease, Hepatology, 41, 372, 10.1002/hep.20554 Browning, 2004, Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity, Hepatology, 40, 1387, 10.1002/hep.20466 Daly, 2011, Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease, Expert Rev Gastroenterol Hepatol, 5, 253, 10.1586/egh.11.18 Rubin, 1968, Alcohol-induced hepatic injury in nonalcoholic volunteers, N Engl J Med, 278, 869, 10.1056/NEJM196804182781602 Kwon, 2013, Effect of lifetime alcohol consumption on the histological severity of non-alcoholic fatty liver disease, Liver Int, 34, 129, 10.1111/liv.12230 Singal, 2014, Alcoholic hepatitis: current challenges and future directions, Clin Gastroenterol Hepatol, 12, 555, 10.1016/j.cgh.2013.06.013 Dam-Larsen, 2009, Final results of a long-term, clinical follow-up in fatty liver patients, Scand J Gastroenterol, 44, 1236, 10.1080/00365520903171284 Mathurin, 2007, Fibrosis progression occurs in a subgroup of heavy drinkers with typical histological features, Aliment Pharmacol Ther, 25, 1047, 10.1111/j.1365-2036.2007.03302.x Deleuran, 2012, Cirrhosis and mortality risks of biopsy-verified alcoholic pure steatosis and steatohepatitis: a nationwide registry-based study, Aliment Pharmacol Ther, 35, 1336, 10.1111/j.1365-2036.2012.05091.x Dunn, 2012, The interaction of rs738409, obesity, and alcohol: a population-based autopsy study, Am J Gastroenterol, 107, 1668, 10.1038/ajg.2012.285 Long, 2016, The Framingham Heart Study - 67 years of discovery in metabolic disease, Nat Rev Endocrinol, 12, 177, 10.1038/nrendo.2015.226 Sayiner, 2016, Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in the United States and the rest of the world, Clin Liver Dis, 20, 205, 10.1016/j.cld.2015.10.001 Adams, 2005, The histological course of non-alcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies, J Hepatol, 42, 132, 10.1016/j.jhep.2004.09.012 Geurts, 2014, Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics, Benef Microbes, 5, 3, 10.3920/BM2012.0065 Szabo, 2015, Gut-liver axis in alcoholic liver disease, Gastroenterology, 148, 30, 10.1053/j.gastro.2014.10.042 Malaguarnera, 2014, Gut microbiota in alcoholic liver disease: pathogenetic role and therapeutic perspectives, World J Gastroenterol, 20, 16639, 10.3748/wjg.v20.i44.16639 Sookoian, 2013, Systems biology elucidates common pathogenic mechanisms between nonalcoholic and alcoholic-fatty liver disease, PLoS One, 8, e58895, 10.1371/journal.pone.0058895 Bajaj, 2012, The intestinal microbiota and liver disease, Am J Gastroenterol Suppl, 1, 9, 10.1038/ajgsup.2012.3 Boursier, 2016, The severity of NAFLD is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota, Hepatology, 63, 764, 10.1002/hep.28356 Otgonsuren, 2013, Anthropometric and clinical factors associated with mortality in subjects with nonalcoholic fatty liver disease, Dig Dis Sci, 58, 1132, 10.1007/s10620-012-2446-3 Ong, 2008, Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease, J Hepatol, 49, 608, 10.1016/j.jhep.2008.06.018 Ekstedt, 2006, Long-term followup of patients with NAFLD and elevated liver enzymes, Hepatology, 44, 865, 10.1002/hep.21327 Stepanova, 2013, Predictors of all-cause mortality and liver-related mortality in patients with non-alcoholic fatty liver disease, Dig Dis Sci, 58, 3017, 10.1007/s10620-013-2743-5 Rafiq, 2009, Long-term follow-up of patients with nonalcoholic fatty liver, Clin Gastroenterol Hepatol, 7, 61, 10.1016/j.cgh.2008.11.005 Adams, 2010, Nonalcoholic fatty liver disease increases risk of death among patients with diabetes: a community-based cohort study, Am J Gastroenterol, 105, 1567, 10.1038/ajg.2010.18 Sesti, 2014, Association between noninvasive fibrosis markers and cardio-vascular organ damage among adults with hepatic steatosis, PLoS One, 9, e104941, 10.1371/journal.pone.0104941 Dam-Larsen, 2004, Long term prognosis of fatty liver: risk of chronic liver disease and death, Gut, 53, 750, 10.1136/gut.2003.019984 Matteoni, 1999, Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity, Gastroenterology, 116, 1413, 10.1016/S0016-5085(99)70506-8 Younossi, 2011, Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality, Hepatology, 53, 1874, 10.1002/hep.24268 Angulo, 2015, Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease, Gastroenterology, 149, 389, 10.1053/j.gastro.2015.04.043 Chedid, 1991, Prognostic factors in alcoholic liver disease. VA Cooperative Study Group, Am J Gastroenterol, 86, 210 Deleuran, 2012, Cirrhosis and mortality risks of biopsy-verified alcoholic pure steatosis and steatohepatitis: a nationwide registry-based study, Aliment Pharmacol Ther, 35, 1336, 10.1111/j.1365-2036.2012.05091.x Sandahl, 2011, Incidence and mortality of alcoholic hepatitis in Denmark 1999-2008: a nationwide population based cohort study, J Hepatol, 54, 760, 10.1016/j.jhep.2010.07.016 Welzel, 2013, Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States, Am J Gastroenterol, 108, 1314, 10.1038/ajg.2013.160 Welzel, 2011, Metabolic syndrome increases the risk of primary liver cancer in the United States: a population-based case-control study, Hepatology, 54, 463, 10.1002/hep.24397 Younossi, 2015, Association of nonalcoholic fatty liver disease with hepatocellular carcinoma in the United States from 2004 to 2009, Hepatology, 62, 1723, 10.1002/hep.28123 Mittal, 2016, Hepatocellular carcinoma in the absence of cirrhosis in United States veterans is associated with nonalcoholic fatty liver disease, Clin Gastroenterol Hepatol, 14, 124, 10.1016/j.cgh.2015.07.019 Xie, 2013, Characteristics of alcoholic liver disease and predictive factors for mortality of patients with alcoholic cirrhosis, Hepatobiliary Pancreat Dis Int, 2, 594, 10.1016/S1499-3872(13)60094-6 Donato, 2002, Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women, Am J Epidemiol, 155, 323, 10.1093/aje/155.4.323 Younossi, 2013, Moderate, excessive or heavy alcohol consumption: each is significantly associated with increased mortality in patients with chronic hepatitis C, Aliment Pharmacol Ther, 37, 703, 10.1111/apt.12265 Loomba, 2013, Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study, Am J Epidemiol, 177, 333, 10.1093/aje/kws252 Mirza, 2011, Obesity, visceral fat, and NAFLD: querying the role of adipokines in the progression of nonalcoholic fatty liver disease, Gastroenterology, 2011, 592404 Singal, 2014, The effect of PNPLA3 on fibrosis progression and development of hepatocellular carcinoma: a meta-analysis, Am J Gastroenterol, 109, 325, 10.1038/ajg.2013.476 Salameh, 2015, PNPLA3 gene polymorphism is associated with predisposition to and severity of alcoholic liver disease, Am J Gastroenterol, 110, 846, 10.1038/ajg.2015.137 Golabi, 2016, Non-alcoholic fatty liver disease is associated with impairment of health related quality of life, Health Qual Life Outcomes, 14, 18, 10.1186/s12955-016-0420-z Les, 2010, Quality of life in cirrhosis is related to potentially treatable factors, Eur J Gastroenterol Hepatol, 22, 221, 10.1097/MEG.0b013e3283319975 Thiele, 2013, Predictors of health-related quality of life in outpatients with cirrhosis: results from a prospective cohort, Hepat Res Treat, 2013, 479639 Younossi, 2014, Clinical outcomes and resource utilization in Medicare patients with chronic liver disease: a historical cohort study, BMJ Open, 4, e004318, 10.1136/bmjopen-2013-004318